Skip to Content

Is the iPad Just An Expensive Plaything for the Rich?

Why other tablet makers shouldn’t bet on matching the iPad’s success.

Are you surprised that a device that costs $600 and that, by most accounts, isn’t essential to work or possibly even your entertainment is purchased by people with lots of disposable income who might be inclined to blow that disposable income on other equally useless things (apps)?

Well, some people are – specifically, those who look at how much iPad users buy when they’re not blowing their cash on iPads. To be fair, Yudu media’s analysis of the “Selling power of the iPad” at least quantifies the profligate spending habits of technology’s early adopters.

That’s great, and it’s clear other tablet makers want to capitalize on that market – after all, the Motorola XOOM, which is apparently the best thing in the world (since the iPad), is going to cost $800. But when does this market reach saturation? Tablets are still an unstable category, and it’s not clear that they won’t go the way of netbook sales at some point – especially if they don’t become cheaper.

And that’s where things get interesting. Does a tablet purchased from Walgreens for $100 grant its user the same magic purchasing power as an iPad? Of course not – it’s catering to a completely different demographic. And so, as tablets become democratized, they’ll become no more, or less, lucrative as a mechanism for delivering media or purchasing experiences than the computers they supplant. One of Apple’s secrets is that the app stores for the iPad and to a lesser extent the iPhone / iPod Touch are proprietary walled gardens disproportionately inhabited by the wealthy and/or spendthrift.

Yet for tablets to succeed, they must come down in price: witness the success of Amazon’s Kindle in the wake of the downward revision of its price. Johnny-come-lately tablet makers and everyone who would sell their wares on these devices should be wary of anyone arguing that tablets are necessarily a route to riches: they can be, but only to the extent that they remain a plaything of the economic elite.

Follow Mims on Twitter or contact him via email.

Keep Reading

Most Popular

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.